Matinas BioPharma Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 59.73 K | $112.88 K | 0.00% | 1.17% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 55.97 K | $105.81 K | 0.86% | 1.10% |
| BLACKROCK, INC. | 11/12/2025 | 49.65 K | $93.84 K | 0.00% | 0.98% |
| SARGENT INVESTMENT GROUP, LLC | 11/14/2025 | 36.62 K | $69.21 K | 2.81% | 0.72% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 28.27 K | $53.43 K | 14.59% | 0.56% |
| NORTHERN TRUST CORP | 11/14/2025 | 22.59 K | $42.70 K | 100.00% | 0.44% |
| STATE STREET CORP | 11/14/2025 | 15.32 K | $28.96 K | 0.00% | 0.30% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 12.56 K | $23.74 K | 100.00% | 0.25% |
| HRT FINANCIAL LP | 11/14/2025 | 10.78 K | $20.00 K | 100.00% | 0.21% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.45 K | $2.73 K | 31.22% | 0.03% |
| CITIGROUP INC | 11/10/2025 | 1.26 K | $2.38 K | 100.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 979 | $1.85 K | -0.31% | 0.02% |
| MORGAN STANLEY | 11/14/2025 | 561 | $1.06 K | 289.58% | 0.01% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 500 | $945 | 100.00% | 0.01% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 422 | $798 | 8,340.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 210 | $394 | 0.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 200 | $378 | 81.82% | 0.00% |
| COSTELLO ASSET MANAGEMENT, INC | 11/06/2025 | 200 | $378 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 102 | $193 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/12/2025 | 61 | $115 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 60 | $114 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 60 | $113 | 0.00% | 0.00% |
| VISION FINANCIAL MARKETS LLC | 11/06/2025 | 40 | $76 | 0.00% | 0.00% |
| ROTHSCHILD INVESTMENT LLC | 11/07/2025 | 14 | $26 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 11 | $21 | 0.00% | 0.00% |
| FMR LLC | 11/13/2025 | 5 | $9 | 150.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 2 | $4 | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Matinas BioPharma Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 41 institutional investors and hedge funds held shares of Matinas BioPharma Holdings, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 59,725
GEODE CAPITAL MANAGEMENT, LLC: 55,970
BlackRock, Inc.: 49,650
Sargent Investment Group, LLC: 36,620
RENAISSANCE TECHNOLOGIES LLC: 28,270
NORTHERN TRUST CORP: 22,594
5.85% of Matinas BioPharma Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.52 M shares in the last 24 months. This purchase volume represents approximately $6.83 M in transactions.